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Erratum to: J Thorac Dis 2018;10:1230-2
Inequivalence of non-aggressiveness in clinically diagnosed lung cancers and overdiagnosis in lung cancer screening trials
Since the publication of the article that appeared on pages 1230–1232, Vol 10, No 3 (1) (March 2018) issue of the Journal of 
Thoracic Disease, additional follow-up of the Danish Lung Cancer Screening Trial has come to my attention.
The contents and related references were originally showed as:
“(IV) OD, measured as the excess cancers in screened vs. control cohorts after completion of follow-up, will be far 
higher in CT than in CR trials. In the large CR trials, the excess was 22–24% (11); in the NLST (vs. CR controls) it was 
18% (5). The sum of the excess in CR vs. unscreened plus the CT vs. CR controls, 23% + (≥18%) ≥41%. In the three 
reporting European trials of CT vs. unscreened controls, the pooled excess was 48% (12-14).
12. Saghir Z, Dirksen A, Ashraf H, et al. CT screening for lung cancer brings forward early disease. The randomised 
Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax 
2012;67:296-301.
13. Pastorino U, Rossi M, Rosato V, et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year 
results of the MILD trial. Eur J Cancer Prev 2012;21:308-315.
14. Infante M, Cavuto S, Lutman FR, et al. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of 
Lung Cancer Screening with Spiral Computed Tomography. Am J Respir Crit Care Med 2015;191:1166-1175.”
The datum of 48% should be updated as 42% and reference 12 should be changed. The updated information is as follows:
“(IV) OD, measured as the excess cancers in screened vs. control cohorts after completion of follow-up, will be far 
higher in CT than in CR trials. In the large CR trials, the excess was 22–24% (11); in the NLST (vs. CR controls) it was 
18% (5). The sum of the excess in CR vs. unscreened plus the CT vs. CR controls, 23% + (≥18%) ≥41%. In the three 
reporting European trials of CT vs. unscreened controls, the pooled excess was 42% (12-14).
12. Wille MM, Dirksen A, Haseem A, et al. Results of the randomized danish lung cancer screening trial with focus on 
high-risk profiling. Am J Respir Crit Care Med 2016;193:542-561.
13. Pastorino U, Rossi M, Rosato V, et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year 
results of the MILD trial. Eur J Cancer Prev 2012;21:308-315.
14. Infante M, Cavuto S, Lutman FR, et al. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of 
Lung Cancer Screening with Spiral Computed Tomography. Am J Respir Crit Care Med 2015;191:1166-1175.”
All authors agree to the erratum of the paper. We apologize for the inconvenience caused. 
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